Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications.


Journal

International journal of legal medicine
ISSN: 1437-1596
Titre abrégé: Int J Legal Med
Pays: Germany
ID NLM: 9101456

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 05 03 2019
accepted: 22 05 2019
pubmed: 4 6 2019
medline: 3 4 2020
entrez: 3 6 2019
Statut: ppublish

Résumé

MDPV is a synthetic cathinone illegally marketed and consumed for its psychostimulant effects, which are similar to those produced by cocaine, amphetamines, and MDMA. Clinical reports indicate that MDPV produces euphoria, increases alertness, and at high doses causes agitation, psychosis, tachycardia and hypertension, hallucinations, delirium, hyperthermia, rhabdomyolysis, and even death. In rodents, MDPV reproduces the typical physiological effects of psychostimulant drugs, demonstrating greater potency than cocaine. Nevertheless, its role in aggressive behavior has been reported but not yet experimentally confirmed. Therefore, the aim of this study was to evaluate the effects of acute and repeated MDPV (0.01-10 mg/kg i.p.) administration on aggressive behavior in mice and to compare them with those of cocaine (0.01-10 mg/kg i.p.) administration. To this purpose, the resident-intruder test in isolated mice and the spontaneous and stimulated aggressiveness tests for group-housed mice were employed. The present study shows for the first time that MDPV enhances aggressive behavior and locomotion in mice with greater potency and efficacy than cocaine treatment. Moreover, the aggressive and locomotor responses are enhanced after repeated administration, indicating that a sensitization mechanism comes into play. These results, although from preclinical investigation, are suggestive that human MDPV intake could be a problem for public health and the criminal justice system. Thus, investigation by police officers and medical staff is needed to prevent interpersonal violence induced by the consumption of synthetic cathinones.

Identifiants

pubmed: 31154497
doi: 10.1007/s00414-019-02092-3
pii: 10.1007/s00414-019-02092-3
doi:

Substances chimiques

Benzodioxoles 0
Narcotics 0
Psychotropic Drugs 0
Pyrrolidines 0
Synthetic Drugs 0
Cocaine I5Y540LHVR
Synthetic Cathinone 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1797-1808

Subventions

Organisme : Drug Policies Department, Presidency of the Council of Ministers, Italy
ID : Effects of NPS: development of a multicentre research for the information enhancement of the Early Warning System
Organisme : Università degli Studi di Ferrara
ID : FAR 2016
Organisme : Università degli Studi di Ferrara
ID : FAR 2017
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : RBFR12LDOW

Commentaires et corrections

Type : CommentIn

Références

European Monitoring Centre for Drugs and Drug Addiction (2018) European drug report 2018: trends and developments. Publications Office of the European Union, Luxembourg Available at http://www.emcdda.europa.eu/publications/edr/trends-developments/2018 . Accessed 29 October 2018
World Drug Report (2018) United Nations publication, sales no. E.18.XI.9. Available at https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_3_DRUG_MARKETS.pdf . Accessed 29 October 2018
Wakabayashi KT, Ren SE, Kiyatkin EA (2015) Methylenedioxypyrovalerone (MDPV) mimics cocaine in its physiological and behavioral effects but induces distinct changes in NAc glucose. Front Neurosci 9:324–324. https://doi.org/10.3389/fnins.2015.00324
doi: 10.3389/fnins.2015.00324 pubmed: 26441499 pmcid: 4584974
Miliano C, Serpelloni G, Rimondo C, Mereu M, Marti M, De Luca MA (2016) Neuropharmacology of new psychoactive substances (NPS): focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants. Front Neurosci 10:153. https://doi.org/10.3389/fnins.2016.00153
doi: 10.3389/fnins.2016.00153 pubmed: 27147945 pmcid: 4835722
Coppola M, Mondola R (2012) 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 208(1):12–15. https://doi.org/10.1016/j.toxlet.2011.10.002
doi: 10.1016/j.toxlet.2011.10.002 pubmed: 22008731
Karila L, Megarbane B, Cottencin O, Lejoyeux M (2015) Synthetic cathinones: a new public health problem. Curr Neuropharmacol 13(1):12–20. https://doi.org/10.2174/1570159x13666141210224137
doi: 10.2174/1570159x13666141210224137 pubmed: 26074740 pmcid: 4462036
Thornton SL, Gerona RR, Tomaszewski CA (2012) Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification. J Med Toxicol 8(3):310–313. https://doi.org/10.1007/s13181-012-0232-4
doi: 10.1007/s13181-012-0232-4 pubmed: 22528592 pmcid: 3550171
Kesha K, Boggs CL, Ripple MG, Allan CH, Levine B, Jufer-Phipps R, Doyon S, Chi P, Fowler DR (2013) Methylenedioxypyrovalerone (“bath salts”), related death: case report and review of the literature. J Forensic Sci 58(6):1654–1659. https://doi.org/10.1111/1556-4029.12202
doi: 10.1111/1556-4029.12202 pubmed: 23822613
Beck O, Franzen L, Backberg M, Signell P, Helander A (2015) Intoxications involving MDPV in Sweden during 2010-2014: results from the STRIDA project. Clin Toxicol (Phila) 53(9):865–873. https://doi.org/10.3109/15563650.2015.1089576
doi: 10.3109/15563650.2015.1089576
Froberg BA, Levine M, Beuhler MC, Judge BS, Moore PW, Engebretsen KM, McKeown NJ, Rosenbaum CD, Young AC, Rusyniak DE (2015) Acute methylenedioxypyrovalerone toxicity. J Med Toxicol 11(2):185–194. https://doi.org/10.1007/s13181-014-0446-8
doi: 10.1007/s13181-014-0446-8 pubmed: 25468313
White CM (2016) Mephedrone and 3,4-methylenedioxypyrovalerone (MDPV): synthetic cathinones with serious health implications. J Clin Pharmacol 56(11):1319–1325. https://doi.org/10.1002/jcph.742
doi: 10.1002/jcph.742 pubmed: 27029951
Diestelmann M, Zangl A, Herrle I, Koch E, Graw M, Paul LD (2018) MDPV in forensic routine cases: psychotic and aggressive behavior in relation to plasma concentrations. Forensic Sci Int 283:72–84. https://doi.org/10.1016/j.forsciint.2017.12.003
doi: 10.1016/j.forsciint.2017.12.003 pubmed: 29275216
Schifano F, Corkery J, Ghodse AH (2012) Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, “meow meow”) in the United Kingdom. J Clin Psychopharmacol 32(5):710–714. https://doi.org/10.1097/JCP.0b013e318266c70c
doi: 10.1097/JCP.0b013e318266c70c pubmed: 22926609
Ross EA, Reisfield GM, Watson MC, Chronister CW, Goldberger BA (2012) Psychoactive “bath salts” intoxication with methylenedioxypyrovalerone. Am J Med 125(9):854–858. https://doi.org/10.1016/j.amjmed.2012.02.019
doi: 10.1016/j.amjmed.2012.02.019 pubmed: 22682791
Marinetti LJ, Antonides HM (2013) Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol 37(3):135–146. https://doi.org/10.1093/jat/bks136
doi: 10.1093/jat/bks136 pubmed: 23361867
Stevenson R, Tuddenham L (2014) Novel psychoactive substance intoxication resulting in attempted murder. J Forensic Legal Med 25:60–61. https://doi.org/10.1016/j.jflm.2014.04.007
doi: 10.1016/j.jflm.2014.04.007
Chermack ST, Fuller BE, Blow FC (2000) Predictors of expressed partner and non-partner violence among patients in substance abuse treatment. Drug Alcohol Depend 58(1–2):43–54
pubmed: 10669054
Narvaez JC, Jansen K, Pinheiro RT, Kapczinski F, Silva RA, Pechansky F, Magalhaes PV (2014) Violent and sexual behaviors and lifetime use of crack cocaine: a population-based study in Brazil. Soc Psychiatry Psychiatr Epidemiol 49(8):1249–1255. https://doi.org/10.1007/s00127-014-0830-3
doi: 10.1007/s00127-014-0830-3 pubmed: 24519271
Marusich JA, Grant KR, Blough BE, Wiley JL (2012) Effects of synthetic cathinones contained in “bath salts” on motor behavior and a functional observational battery in mice. Neurotoxicology 33(5):1305–1313. https://doi.org/10.1016/j.neuro.2012.08.003
doi: 10.1016/j.neuro.2012.08.003 pubmed: 22922498 pmcid: 3475178
Gatch MB, Taylor CM, Forster MJ (2013) Locomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinones. Behav Pharmacol 24(5–6):437–447. https://doi.org/10.1097/FBP.0b013e328364166d
doi: 10.1097/FBP.0b013e328364166d pubmed: 23839026 pmcid: 4183201
Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology 38(4):552–562. https://doi.org/10.1038/npp.2012.204
doi: 10.1038/npp.2012.204 pubmed: 23072836
Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013) In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 38(4):563–573. https://doi.org/10.1038/npp.2012.233
doi: 10.1038/npp.2012.233 pubmed: 23212455
Giannotti G, Canazza I, Caffino L, Bilel S, Ossato A, Fumagalli F, Marti M (2017) The cathinones MDPV and alpha-PVP elicit different behavioral and molecular effects following acute exposure. Neurotox Res 32(4):594–602. https://doi.org/10.1007/s12640-017-9769-y
doi: 10.1007/s12640-017-9769-y pubmed: 28646469
Takahashi A, Quadros IM, de Almeida RM, Miczek KA (2012) Behavioral and pharmacogenetics of aggressive behavior. Curr Top Behav Neurosci 12:73–138. https://doi.org/10.1007/7854_2011_191
doi: 10.1007/7854_2011_191 pubmed: 22297576 pmcid: 3864145
Miczek KA, O'Donnell JM (1978) Intruder-evoked aggression in isolated and nonisolated mice: effects of psychomotor stimulants and L-dopa. Psychopharmacology 57(1):47–55
doi: 10.1007/BF00426957
Nelson M, Pinna G (2011) S-norfluoxetine microinfused into the basolateral amygdala increases allopregnanolone levels and reduces aggression in socially isolated mice. Neuropharmacology 60(7–8):1154–1159. https://doi.org/10.1016/j.neuropharm.2010.10.011
doi: 10.1016/j.neuropharm.2010.10.011 pubmed: 20971127
Canazza I, Ossato A, Trapella C, Fantinati A, De Luca MA, Margiani G, Vincenzi F, Rimondo C, Di Rosa F, Gregori A, Varani K, Borea PA, Serpelloni G, Marti M (2016) Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Psychopharmacology 233(21–22):3685–3709. https://doi.org/10.1007/s00213-016-4402-y
doi: 10.1007/s00213-016-4402-y pubmed: 27527584
Darmani NA, Hadfield MG, Carter WH Jr, Martin BR (1990) Acute and chronic effects of cocaine on isolation-induced aggression in mice. Psychopharmacology 102(1):37–40
doi: 10.1007/BF02245741
Ossato A, Canazza I, Trapella C, Vincenzi F, De Luca MA, Rimondo C, Varani K, Borea PA, Serpelloni G, Marti M (2016) Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 67:31–50. https://doi.org/10.1016/j.pnpbp.2016.01.007
doi: 10.1016/j.pnpbp.2016.01.007
Miczek KA (1979) A new test for aggression in rats without aversive stimulation: differential effects of d-amphetamine and cocaine. Psychopharmacology 60(3):253–259
doi: 10.1007/BF00426664
Rademacher DJ, Schuyler AL, Kruschel CK, Steinpreis RE (2002) Effects of cocaine and putative atypical antipsychotics on rat social behavior: an ethopharmacological study. Pharmacol Biochem Behav 73(4):769–778
doi: 10.1016/S0091-3057(02)00904-8
Hadfield MG, Nugent EA, Mott DE (1982) Cocaine increases isolation-induced fighting in mice. Pharmacol Biochem Behav 16(2):359–360
doi: 10.1016/0091-3057(82)90172-1
Hoaken PN, Stewart SH (2003) Drugs of abuse and the elicitation of human aggressive behavior. Addict Behav 28(9):1533–1554
doi: 10.1016/j.addbeh.2003.08.033
de Almeida RM, Ferrari PF, Parmigiani S, Miczek KA (2005) Escalated aggressive behavior: dopamine, serotonin and GABA. Eur J Pharmacol 526(1–3):51–64. https://doi.org/10.1016/j.ejphar.2005.10.004
doi: 10.1016/j.ejphar.2005.10.004 pubmed: 16325649
Baumann MH, Partilla JS, Lehner KR (2013) Psychoactive “bath salts”: not so soothing. Eur J Pharmacol 698(1–3):1–5. https://doi.org/10.1016/j.ejphar.2012.11.020
doi: 10.1016/j.ejphar.2012.11.020 pubmed: 23178799
Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, Brandt SD, Baumann MH (2016) Reinforcing and neurochemical effects of the “bath salts” constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233(10):1981–1990. https://doi.org/10.1007/s00213-015-4057-0
doi: 10.1007/s00213-015-4057-0 pubmed: 26319160
Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013) Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85(12):1803–1815. https://doi.org/10.1016/j.bcp.2013.04.004
doi: 10.1016/j.bcp.2013.04.004 pubmed: 23583454 pmcid: 3692398
Hondebrink L, Zwartsen A, Westerink RHS (2018) Effect fingerprinting of new psychoactive substances (NPS): what can we learn from in vitro data? Pharmacol Ther 182:193–224. https://doi.org/10.1016/j.pharmthera.2017.10.022
doi: 10.1016/j.pharmthera.2017.10.022 pubmed: 29097307
Baumann MH, Bukhari MO, Lehner KR, Anizan S, Rice KC, Concheiro M, Huestis MA (2017) Neuropharmacology of 3,4-methylenedioxypyrovalerone (MDPV), its metabolites, and related analogs. Curr Top Behav Neurosci 32:93–117. https://doi.org/10.1007/7854_2016_53
doi: 10.1007/7854_2016_53 pubmed: 27830575 pmcid: 5392131
Lopez-Arnau R, Duart-Castells L, Aster B, Camarasa J, Escubedo E, Pubill D (2018) Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine. Psychopharmacology. https://doi.org/10.1007/s00213-018-5052-z
doi: 10.1007/s00213-018-5052-z
Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME (2013) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168(2):458–470. https://doi.org/10.1111/j.1476-5381.2012.02145.x
doi: 10.1111/j.1476-5381.2012.02145.x pubmed: 22897747
Essman WD, Singh A, Lucki I (1994) Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine. Pharmacol Biochem Behav 49(1):107–113
doi: 10.1016/0091-3057(94)90463-4
Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y (2004) Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal. Prog Neuro-Psychopharmacol Biol Psychiatry 28(1):157–171. https://doi.org/10.1016/j.pnpbp.2003.09.032
doi: 10.1016/j.pnpbp.2003.09.032
Verheij MM, Karel P, Cools AR, Homberg JR (2014) Reduced cocaine-induced serotonin, but not dopamine and noradrenaline, release in rats with a genetic deletion of serotonin transporters. Eur Neuropsychopharmacol 24(11):1850–1854. https://doi.org/10.1016/j.euroneuro.2014.09.004
doi: 10.1016/j.euroneuro.2014.09.004 pubmed: 25261262
Yoshimoto K, Kato B, Ueda S, Noritake K, Sakai K, Shibata M, Hori M, Kawano H, Takeuchi Y, Wakabayashi Y, Yasuhara M (2001) Dopamine and serotonin uptake inhibitors on the release of dopamine and serotonin in the nucleus accumbens of young and aged rats. Mech Ageing Dev 122(15):1707–1721
doi: 10.1016/S0047-6374(01)00292-5
Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch KP, Murphy DL, Hall FS, Uhl GR, Sora I (2004) Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29(10):1790–1799. https://doi.org/10.1038/sj.npp.1300476
doi: 10.1038/sj.npp.1300476 pubmed: 15226739
Nelson RJ, Chiavegatto S (2001) Molecular basis of aggression. Trends Neurosci 24(12):713–719
doi: 10.1016/S0166-2236(00)01996-2
DeLeon KR, Grimes JM, Connor DF, Melloni RH Jr (2002) Adolescent cocaine exposure and offensive aggression: involvement of serotonin neural signaling and innervation in male Syrian hamsters. Behav Brain Res 133(2):211–220
doi: 10.1016/S0166-4328(02)00004-9
Knyshevski I, Ricci LA, McCann TE, Melloni RH Jr (2005) Serotonin type-1A receptors modulate adolescent, cocaine-induced offensive aggression in hamsters. Physiol Behav 85(2):167–176. https://doi.org/10.1016/j.physbeh.2005.03.020
doi: 10.1016/j.physbeh.2005.03.020 pubmed: 15885719
Drouin C, Blanc G, Villegier AS, Glowinski J, Tassin JP (2002) Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics. Synapse (New York, NY) 43(1):51–61. https://doi.org/10.1002/syn.10023
doi: 10.1002/syn.10023
Kalivas PW, Duffy P (1993) Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13(1):266–275
doi: 10.1523/JNEUROSCI.13-01-00266.1993
Berquist MD 2nd, Traxler HK, Mahler AM, Baker LE (2016) Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats. Drug Alcohol Depend 164:128–134. https://doi.org/10.1016/j.drugalcdep.2016.05.001
doi: 10.1016/j.drugalcdep.2016.05.001 pubmed: 27181413 pmcid: 4899829
Watterson LR, Kufahl PR, Taylor SB, Nemirovsky NE, Olive MF (2016) Sensitization to the motor stimulant effects of 3,4-methylenedioxypyrovalerone (MDPV) and cross-sensitization to methamphetamine in rats. J Drug Alcohol Res 5:1–10. https://doi.org/10.4303/jdar/235967
doi: 10.4303/jdar/235967
Kohler RJ, Perrine SA, Baker LE (2018) Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines. Neuropharmacology 134(Pt A):22–27. https://doi.org/10.1016/j.neuropharm.2017.10.019
doi: 10.1016/j.neuropharm.2017.10.019 pubmed: 29042316
Zaniewska M, Filip M, Przegalinski E (2015) The involvement of norepinephrine in behaviors related to psychostimulant addiction. Curr Neuropharmacol 13(3):407–418
doi: 10.2174/1570159X13666150121225659
Ago M, Ago K, Ogata M (2009) Determination of methamphetamine in sudden death of a traffic accident inpatient by blood and hair analyses. Legal Med 11(Suppl 1):S568–S569. https://doi.org/10.1016/j.legalmed.2009.01.086
doi: 10.1016/j.legalmed.2009.01.086 pubmed: 19269234
Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25–53. https://doi.org/10.1146/annurev.psych.54.101601.145237
doi: 10.1146/annurev.psych.54.101601.145237 pubmed: 12185211
Steketee JD, Kalivas PW (2011) Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 63(2):348–365. https://doi.org/10.1124/pr.109.001933
doi: 10.1124/pr.109.001933 pubmed: 21490129 pmcid: 3082449
Adamowicz P, Gil D, Skulska A, Tokarczyk B (2013) Analysis of MDPV in blood--determination and interpretation. J Anal Toxicol 37(5):308–312. https://doi.org/10.1093/jat/bkt025
doi: 10.1093/jat/bkt025 pubmed: 23572248
Kriikku P, Wilhelm L, Schwarz O, Rintatalo J (2011) New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland. Forensic Sci Int 210(1–3):195–200. https://doi.org/10.1016/j.forsciint.2011.03.015
doi: 10.1016/j.forsciint.2011.03.015 pubmed: 21477955
Kriikku P, Rintatalo J, Pihlainen K, Hurme J, Ojanpera I (2015) The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland. Int J Legal Med 129(4):741–749. https://doi.org/10.1007/s00414-015-1184-4
doi: 10.1007/s00414-015-1184-4 pubmed: 25833171
Maas A, Wippich C, Madea B, Hess C (2015) Driving under the influence of synthetic phenethylamines: a case series. Int J Legal Med 129(5):997–1003. https://doi.org/10.1007/s00414-015-1150-1
doi: 10.1007/s00414-015-1150-1 pubmed: 25618172
Giorgetti R, Tagliabracci A, Schifano F, Zaami S, Marinelli E, Busardo FP (2017) When “Chems” meet sex: a rising phenomenon called “ChemSex”. Curr Neuropharmacol 15(5):762–770. https://doi.org/10.2174/1570159x15666161117151148
doi: 10.2174/1570159x15666161117151148 pubmed: 27855594 pmcid: 5771052
Madea B, Musshoff F (2009) Knock-out drugs: their prevalence, modes of action, and means of detection. Dtsch Arztebl Int 106(20):341–347. https://doi.org/10.3238/arztebl.2009.0341
doi: 10.3238/arztebl.2009.0341 pubmed: 19547737 pmcid: 2689633
Larabi IA, Martin M, Etting I, Penot P, Fabresse N, Alvarez JC (2018) Drug-facilitated sexual assault (DFSA) involving 4-methylethcathinone (4-MEC), 3,4-Methylenedioxypyrovalerone (MDPV), and doxylamine highlighted by hair analysis. Drug Test Anal 10:1280–1284. https://doi.org/10.1002/dta.2377
doi: 10.1002/dta.2377
Birkler RI, Telving R, Ingemann-Hansen O, Charles AV, Johannsen M, Andreasen MF (2012) Screening analysis for medicinal drugs and drugs of abuse in whole blood using ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-TOF-MS)--toxicological findings in cases of alleged sexual assault. Forensic Sci Int 222(1–3):154–161. https://doi.org/10.1016/j.forsciint.2012.05.019
doi: 10.1016/j.forsciint.2012.05.019 pubmed: 22770621
Foti F, Marti M, Ossato A, Bilel S, Sangiorgi E, Botrè F, Cerbelli B, Baldi A, De-Giorgio F (2018) Phenotypic effects of chronic and acute use of methiopropamine in a mouse model. Int J Legal Med 132(4):1225–1230. https://doi.org/10.1007/s00414-018-1891-8
doi: 10.1007/s00414-018-1891-8
Fantinati A, Ossato A, Bianco S, Canazza I, De Giorgio F, Trapella C, Marti M (2017) 1-cyclohexyl-x-methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice. Hum Psychopharmacol 32(3). https://doi.org/10.1002/hup.2560
doi: 10.1002/hup.2560
Ossato A, Uccelli L, Bilel S, Canazza I, Di Domenico G, Pasquali M, Pupillo G, De Luca MA, Boschi A, Vincenzi F, Rimondo C, Beggiato S, Ferraro L, Varani K, Borea PA, Serpelloni G, De-Giorgio F, Marti M (2017) Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48: behavioral, neurochemical, and dopamine transporter scan imaging studies in mice. Front Psychiatry 8:130. https://doi.org/10.3389/fpsyt.2017.00130
doi: 10.3389/fpsyt.2017.00130 pubmed: 28824464 pmcid: 5543288
Ossato A, Bilel S, Gregori A, Talarico A, Trapella C, Gaudio RM, De-Giorgio F, Tagliaro F, Neri M, Fattore L, Marti M (2018) Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice. Neuropharmacology 141:167–180. https://doi.org/10.1016/j.neuropharm.2018.08.017
doi: 10.1016/j.neuropharm.2018.08.017 pubmed: 30165078

Auteurs

Fabio De-Giorgio (F)

Institute of Public Health, Section of Legal Medicine, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168, Rome, Italy.

Sabrine Bilel (S)

Department of Life Sciences and Biotechnology (SVeB), University of Ferrara, Ferrara, Italy.

Andrea Ossato (A)

Institute of Public Health, Section of Legal Medicine, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168, Rome, Italy.

Micaela Tirri (M)

Collaborative Center for the Italian National Early Warning System, Department of Anti-Drug Policies, Presidency of the Council of Ministers, Ferrara, Italy.
Department of Morphology, Experimental Medicine and Surgery, Section of Legal Medicine and LTTA Centre, University of Ferrara, via Fossato di Mortara 70, 44121, Ferrara, Italy.

Raffaella Arfè (R)

Institute of Public Health, Section of Legal Medicine, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168, Rome, Italy.
Department of Morphology, Experimental Medicine and Surgery, Section of Legal Medicine and LTTA Centre, University of Ferrara, via Fossato di Mortara 70, 44121, Ferrara, Italy.

Federica Foti (F)

Institute of Public Health, Section of Legal Medicine, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168, Rome, Italy.

Giovanni Serpelloni (G)

Department of Psychiatry in the College of Medicine, Drug Policy Institute, University of Florida, Gainesville, FL, USA.

Paolo Frisoni (P)

Department of Morphology, Experimental Medicine and Surgery, Section of Legal Medicine and LTTA Centre, University of Ferrara, via Fossato di Mortara 70, 44121, Ferrara, Italy.

Margherita Neri (M)

Department of Morphology, Experimental Medicine and Surgery, Section of Legal Medicine and LTTA Centre, University of Ferrara, via Fossato di Mortara 70, 44121, Ferrara, Italy.

Matteo Marti (M)

Collaborative Center for the Italian National Early Warning System, Department of Anti-Drug Policies, Presidency of the Council of Ministers, Ferrara, Italy. matteo.marti@unife.it.
Department of Morphology, Experimental Medicine and Surgery, Section of Legal Medicine and LTTA Centre, University of Ferrara, via Fossato di Mortara 70, 44121, Ferrara, Italy. matteo.marti@unife.it.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH